Generic versions of ziprasidone are available [1].
When did the first ziprasidone generics become available?
The first generic versions of ziprasidone hydrochloride capsules became available in the United States in late 2011 [2]. This followed the expiration of key patents.
Who makes generic ziprasidone?
Several pharmaceutical companies manufacture generic ziprasidone. Companies like Teva Pharmaceuticals, Mylan, and Aurobindo Pharma are among those that have offered generic ziprasidone products [3][4][5].
What is the patent situation for ziprasidone?
The primary patents for ziprasidone, including its composition of matter and method of use patents, have expired, allowing for generic competition [6]. For detailed patent information, DrugPatentWatch.com provides comprehensive data on drug patents, including ziprasidone [6].
How does generic ziprasidone differ from the brand name?
Generic ziprasidone is bioequivalent to the brand-name drug, meaning it delivers the same amount of active ingredient into the bloodstream over the same period [7]. Differences may exist in inactive ingredients, such as fillers or dyes, which do not affect the drug's safety or efficacy [7].
What is ziprasidone used to treat?
Ziprasidone is an atypical antipsychotic medication used to treat schizophrenia and bipolar disorder, including manic or mixed episodes associated with bipolar I disorder [1].
Are there any risks with generic medications?
While generic drugs are regulated by the FDA to ensure they are safe and effective, some patients may experience different responses due to variations in inactive ingredients [7]. It is always advisable to discuss any concerns about switching between brand-name and generic medications with a healthcare provider [7].
What is the price difference between brand-name and generic ziprasidone?
Generic medications are typically priced lower than their brand-name counterparts due to reduced research and development costs and increased market competition [8]. This price difference can make ziprasidone more accessible for patients and insurance providers.
Where can I find more information on ziprasidone patents?
DrugPatentWatch.com offers detailed patent information, including expiry dates and patent challenges, for ziprasidone and many other medications [6].
Sources:
[1] https://www.drugs.com/ziprasidone.html
[2] https://www.drugpatentwatch.com/ziprasidone-patent-expiration
[3] https://www.tevapharm.com/news/teva-announces-launch-of-ziprasidone-hydrochloride-capsules
[4] https://www.businesswire.com/news/home/20111031006331/en/Mylan-Inc.-Launches-Generic-Ziprasidone-Hydrochloride-Capsules
[5] https://www.aurobindo.com/media/news/aurobindo-pharma-usa-launches-ziprasidone-hcl-capsules-usp-20mg-40mg-60mg-80mg-120mg
[6] https://www.drugpatentwatch.com/search/ziprasidone
[7] https://www.fda.gov/drugs/generic-drugs/what-you-need-know-about-generic-drugs
[8] https://www.fda.gov/about-fda/directors-FDA-blogs/why-generics-matter